role of rebates in glp-1 pbm decisions Strategies How to Manage Pharmacy Benefit

Do not start a GLP-1 receptor agonist in a patient with a prior diagnosis of gastroparesis

Indias pharma industry is strong

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep out of reach of children

While our current treatments have shown significant therapeutic benefits, there still appear to be some patients who, despite aggressive therapy, good adherence, and inhaler technique, continue to have exacerbations

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

People taking GLP-1 weight loss medications have found some easy ways to get in lots of protein at meals and snacks.